Scynexis
Price & Volume
Stats
See more52W Range | $3.68-$10.48 |
Market Cap | $366.2M |
Shares Short | 320,181 |
Financials
See moreRevenue (12 Mos) | $20.3M |
Revenue Growth (YoY) | 1,808.5% |
Gross Profit (12 Mos) | $20.3M |
Diluted EPS | -$3.84 |
News
See moreYahoo Finance • 2 months ago
SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 7 months ago
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Yahoo Finance • 8 months ago
SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
About
CEO | Dr. David Gonzalez Angulo M.D. |
Address | 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 18 |